Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Sixth International Conference on Alzheimer’s Disease and Related Disorders: Selected Abstracts

Conference Index | Round Tables | Selected Abstracts | News Summaries

Function and Dysfunction of Presenilins in Alzheimer's Disease

S.S. Sisodia

The Department of Pharmacological and Physiological Sciences, The University of Chicago, Chicago, Il. 60637, USA

Autosomal dominant inheritance of mutations in genes on chromosomes 14 and 1, encoding presenilins (PS1 and PS2, respectively) are causative in the vast majority of pedigrees with familial Alzheimer's disease (FAD). Biochemical studies have confirmed that PS are ubiquitously expressed, polytopic membrane proteins that areendoproteolytically processed in vivo; the PS derivatives coassemble in heteromeric complexes that accumulate in a saturable and stoichiometric manner. A PS homologue in C. elegans, termed sel-12, facilitates lin-12/Notch signalling during developent; in worms, human PS complements deficiencies caused by loss of sel-12. The function of PS1 in vertebrate development has been revealed by analysis of mice with inactivated PS1 alleles (PS1-/-); these animals die before birth, and exhibit axial skeletal deficits and cerebral hemorrhages. In mid-gestation PS1-/- embryos, somite segmentation is disrupted, and expression of Notch 1 and Dll1 mRNAs are abolished in the presomitic mesoderm. The developmental phenotypes of PS1-/- embryos can be rescued with transgenes encoding either wild-type or FAD-linked A246E human PS1, arguing that FAD-linked mutant PS1 retain normal function during embryonic development. The mechanism(s) by which mutant PS cause AD are not fully clarified, but expression of FAD-linked PS1 leads to elevated production of Ab42 peptides and acceleration of Ab deposition in brains of transgenic mice. Remarkably, studies of primary cultures from PS1-/- mice reveal that PS1 enhances APPsa secretion coincident with inhibited Ab secretion. While these studies directly implicate PS1 in the regulation of APP/Ab metabolism, evidence is emerging that PS1 plays a more general role in secretory trafficking and metabolism. Future efforts aimed at identifying molecules which facilitate PS1 function will be critical for understanding the role of PS1 in the secretory/endocytic apparatus in normal and pathogenic settings.

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad